Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
0
Number of overlapping holdings
0.0%
% of PBE's 28 holdings also in WGRO
nan%
% of WGRO's 70 holdings also in PBE
Overlap by Weight
Sector Drift (PBE minus WGRO)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PBE |
Weight in WGRO |
Overlap | |
|---|---|---|---|---|
Position Highlights (Non-Overlapping Exposures)
PBE Overweight Relative to WGRO
 |
NEUROCRINE BIOSCIENCES INC | 5.5% |
|
NATERA INC | 5.4% |
|
GILEAD SCIENCES INC | 4.8% |
|
UNITED THERAPEUTICS CORP | 4.6% |
|
AMGEN INC | 4.6% |
|
BIOGEN IDEC INC | 4.5% |
|
ILLUMINA INC | 4.4% |
|
REGENERON PHARMACEUTICALS | 4.0% |
|
PROTAGONIST THERAPEUTICS, INC. | 3.7% |
|
BIOCRYST PHARMACEUTICALS INC | 3.6% |
PBE Underweight Relative to WGRO
|
MYRIAD GENETICS INC | 1.0% |
|
XENCOR INC | 1.7% |
|
DYNAVAX TECHNOLOGIES CORP | 2.1% |
|
CAREDX, INC. | 2.2% |
|
BIO-TECHNE CORPORATION | 2.3% |
|
INCYTE CORP | 2.4% |
|
BIOMARIN PHARMACEUTICAL INC | 2.5% |
|
PTC THERAPEUTICS INC | 2.6% |
|
VERACYTE INC | 2.7% |
|
ACADIA PHARMACEUTICALS INC | 2.8% |